NCT06830811

Brief Summary

The purpose of this research is to collect medical imaging data to allow for the comparison of bone mineral density measurements from two low-dose x-ray exams. The main question it aims to answer is: What is the precision measurement between the BMD assessments from 2 x-ray exams?

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 13, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

February 12, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 17, 2025

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

February 17, 2025

Status Verified

February 1, 2025

Enrollment Period

3 months

First QC Date

February 12, 2025

Last Update Submit

February 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • AP Spine BMD Precision

    Calculation of EOSedge BMD from the 2 exams will be post-processed from the bi-planar EOSedge 2E radiographs, and is measured in g/cm² surface mass on four lumbar vertebrae (L1-L4) in the anteroposterior (AP) projection. Precision error will be calculated from the 2 exams.

    1 day

Secondary Outcomes (2)

  • Hip BMD Precision

    1 day

  • Lateral L2-L3 Precision

    1 day

Study Arms (1)

Subjects indicated for EOSedge imaging

OTHER

Subject receiving EOSedge imaging as SOC will also receive an additional EOSedge scan.

Radiation: EOSedge imaging

Interventions

Full body or full spine image

Subjects indicated for EOSedge imaging

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects indicated for full-spine or whole-body radiography via EOSedge 2E biplanar imaging (e.g., in the preoperative evaluation of spine and/or other orthopaedic conditions)
  • Male or female subjects who are at least 20 years of age at the time of imaging acquisition
  • Written informed consent obtained from the potential subject or the subject's legal representative and ability for the subject to comply with the requirements of the study

You may not qualify if:

  • Subjects who have been administered contrast agents or radionuclides within 7 days prior to scheduled radiographic imaging (EOS and DXA)
  • Subjects who are pregnant or wanting to become pregnant during the timeframe of study participation (due to risks associated with radiographic imaging)
  • Subjects with a BMI ≥ 35 kg/m2
  • Subjects known to have severe degenerative changes or fracture deformity in the measurement area (i.e., lumbar spine L1-L4, bilateral femoral neck/trochanter; note that unilateral femoral evaluation is acceptable), as defined by the Investigator's determination of the likelihood of reasonably assessing bone mineral density of those areas
  • Subjects known to have implants, hardware, devices, or other foreign material in the measurement area (i.e., lumbar spine L1-L4, bilateral femoral neck/trochanter; note that unilateral femoral evaluation is acceptable)
  • Subjects unable to attain correct position and/or remain motionless for the measurement (e.g., subjects unable to stand unassisted in the EOS unit, or to lie appropriately in the DXA scanner)
  • Subjects known to have extra or missing lumbar vertebrae (i.e., more or fewer than 5 mobile lumbar segments)
  • Subjects participating in another clinical study which may compromise this study's results or compliance with this study's procedures
  • Subjects with presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the subject or the quality of the data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OrthoIndy

Fishers, Indiana, 46038, United States

RECRUITING

Central Study Contacts

Sr. Manager, Clinical Studies

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2025

First Posted

February 17, 2025

Study Start

November 13, 2024

Primary Completion

February 1, 2025

Study Completion

March 1, 2025

Last Updated

February 17, 2025

Record last verified: 2025-02

Locations